EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TriNetX and Real-World Evidence: A Critical Review of Its Strengths, Limitations, and Bias Considerations in Clinical Research

Mahmoud Nassar, Hazem Abosheaishaa, Khaled Elfert, Azizullah Beran, Abdellatif Ismail, Mouhand Mohamed, Anoop Misra, Muhammed Amir Essibayi, David J Altschul, Ahmed Y Azzam

ASIDE Internal Medicine · 22.03.2025 · 1 (2) · 24-32

DOI: 10.71079/aside.im.03222516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ASIDE Internal Medicine, online erschienen am 22.03.2025. Verfasst von Mahmoud Nassar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The increasing utilization of real-world data platforms in medical research necessitates a comprehensive understanding of their methodological strengths and limitations. TriNetX has emerged as a significant platform for exploring large healthcare datasets. This review aims to critically evaluate the methodological framework and limitations of TriNetX, assess the impact of electronic health record coding accuracy on data reliability, and analyze the platform's capacity for generating generalizable real-world evidence in clinical research.

Methods

We conducted a comprehensive review examining TriNetX's data architecture, quality metrics, and research applications, focusing on data integrity, platform architecture, and the external validity of research findings.

Results

The analysis reveals significant methodological considerations. TriNetX's reliance on retrospective data introduces biases such as selection bias and confounding variables. The coding accuracy of electronic health records, which have not been independently validated, is a critical determinant of data reliability. The demographic representation is limited, affecting the generalizability of results.

Discussion

Despite its extensive use, TriNetX's effective utilization requires careful consideration of its inherent limitations. The platform's data, predominantly from insured populations in academic and acute care settings, may not fully represent broader demographic groups. Addressing these methodological constraints is crucial for enhancing the reliability and applicability of research findings derived from TriNetX.

Conclusions

TriNetX is a valuable resource for healthcare research. However, its limitations must be acknowledged, and future research should focus on standardizing data collection and enhancing data validation processes to mitigate platform-specific biases and improve the quality and applicability of the findings.

Schlagwörter

Stichwörter der Autor:innen

Clinical ResearchData QualityReal-World EvidenceResearch MethodologyTriNetX

Autor:innen und Institutionen

  • Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
  • Internal Medicine Department, Icahn School of Medicine at Mount Sinai, NYC H+H Queens, New York, NY, USA.
  • Division of Gastroenterology, West Virginia University School of Medicine, Morgantown, WV, USA.
  • Division of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, USA.
  • Department of Internal Medicine, University of Maryland Medical Center Midtown, Baltimore, MD, USA.
  • Division of Gastroenterology and Hepatology, May Clinic, Rochester, MN, USA.

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Nassar, M., Abosheaishaa, H., Elfert, K., Beran, A., Ismail, A., Mohamed, M., Misra, A., Essibayi, M. A., Altschul, D. J., & Azzam, A. Y. (2025). TriNetX and Real-World Evidence: A Critical Review of Its Strengths, Limitations, and Bias Considerations in Clinical Research. ASIDE Internal Medicine, 1(2), 24-32. https://doi.org/10.71079/aside.im.03222516

Vancouver

Nassar M, Abosheaishaa H, Elfert K, Beran A, Ismail A, Mohamed M, et al. TriNetX and Real-World Evidence: A Critical Review of Its Strengths, Limitations, and Bias Considerations in Clinical Research. ASIDE Internal Medicine. 2025;1(2):24-32. doi:10.71079/aside.im.03222516

BibTeX
@article{Nassar2025,
  author = {Nassar, Mahmoud and Abosheaishaa, Hazem and Elfert, Khaled and Beran, Azizullah and Ismail, Abdellatif and Mohamed, Mouhand and Misra, Anoop and Essibayi, Muhammed Amir and Altschul, David J and Azzam, Ahmed Y},
  title = {TriNetX and Real-World Evidence: A Critical Review of Its Strengths, Limitations, and Bias Considerations in Clinical Research},
  journal = {ASIDE Internal Medicine},
  year = {2025},
  volume = {1},
  number = {2},
  pages = {24--32},
  doi = {10.71079/aside.im.03222516}
}
Kostenlos starten →